Patents by Inventor Andrej Kocijan

Andrej Kocijan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9453030
    Abstract: The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pharmaceutical compositions containing such atorvastatin calcium.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: September 27, 2016
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Rok Grahek, Darko Kocjan, Andrej Bastarda, Andrej Kocijan, Matjaz Kracun
  • Publication number: 20150105551
    Abstract: The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pharmaceutical compositions containing such atorvastatin calcium.
    Type: Application
    Filed: December 18, 2014
    Publication date: April 16, 2015
    Inventors: Rok GRAHEK, Darko KOCJAN, Andrej BASTARDA, Andrej KOCIJAN, Matjaz KRACUN
  • Patent number: 8044086
    Abstract: The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pharmaceutical compositions containing such atorvastatin calcium.
    Type: Grant
    Filed: July 15, 2005
    Date of Patent: October 25, 2011
    Assignee: Lek Pharmaceuticals D.D.
    Inventors: Rok Grahek, Darko Kocjan, Andrej Bastarda, Andrej Kocijan, Matjaz Kracun
  • Publication number: 20110112165
    Abstract: A new compound in which atorvastatin and aliskiren are covalently bound, salts of this compound, pharmaceutical compositions thereof, as well the use of this compound as a medicament and as an impurity standard are provided. Furthermore, a 0 process for the preparation of a compound in which atorvastatin and aliskiren are covalently bound, a method for analyzing a sample of atorvastatin and/or aliskiren, and a method for determining the retention time on a chromatographic system for atorvastatin and/or aliskiren are provided.
    Type: Application
    Filed: January 13, 2009
    Publication date: May 12, 2011
    Inventors: Andrej Kocijan, Matjaz Kracun, Andrej Bastarda, Rok Grahek, Darko Kocjan
  • Publication number: 20100219063
    Abstract: The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pharmaceutical compositions containing such atorvastatin calcium.
    Type: Application
    Filed: April 30, 2010
    Publication date: September 2, 2010
    Applicant: Lek Pharmaceuticals D.D.
    Inventors: Rok GRAHEK, Darko Kocjan, Andrej Bastarda, Andrej Kocijan, Matjaz Kracun
  • Publication number: 20100056605
    Abstract: The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pharmaceutical compositions containing such atorvastatin calcium.
    Type: Application
    Filed: November 6, 2009
    Publication date: March 4, 2010
    Applicant: LEK PHARMACEUTICALS D.D.
    Inventors: Rok Grahek, Darko Kocjan, Andrej Bastarda, Andrej Kocijan, Matjaz Kracun
  • Publication number: 20070208071
    Abstract: The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pharmaceutical compositions containing such atorvastatin calcium.
    Type: Application
    Filed: July 15, 2005
    Publication date: September 6, 2007
    Applicant: LEK PHARMACEUTICALS D.D.
    Inventors: Rok Grahek, Darko Kocjan, Andrej Bastarda, Andrej Kocijan, Matjaz Kracun